Auddia Inc. filed a Current Report disclosing unaudited financial statements for Thramann Holdings, LLC and its subsidiaries (LT350, Influence Healthcare, Voyex) in connection with a proposed business combination. The merger agreement, dated February 17, 2026, provides that Auddia shareholders will own approximately 20% of the combined entity, while Jeff Thramann will hold approximately 80%, receiving consideration via convertible preferred stock and $3.5 million in non-convertible debt. The transaction requires Auddia to maintain at least $12 million in net cash at closing. Pro forma financials indicate a $2.55 million equity financing raise by Auddia, resulting in pro forma combined assets of approximately $17.98 million as of June 30, 2026. Additionally, Auddia provided interim bridge funding of up to $1.4 million to Thramann Holdings at 8% interest, with $920,728 funded by July 2026. Auddia Inc. operates in the technology sector, providing audio software and AI-driven solutions for media and enterprise clients.

On July 17, 2026, Auddia Inc. entered into senior unsecured bridge notes to provide interim working capital to four target companies pending a merger: Thramann Holdings ($360,000), LT350 ($400,000), Influence Healthcare ($590,000), and Voyex ($50,000). The notes carry an 8.0% annual compound interest rate. Notes for LT350, Influence, and Voyex are convertible into equity at a 20% discount upon a qualified financing event. The parties agreed that funds advanced under these notes will count toward Auddia's $12 million net cash closing condition for the merger. A special stockholders meeting to vote on the merger is planned for late August 2026. Auddia operates in the AI sector, providing AI-native audio technology solutions.